Modifying the release of leuprolide from spray dried OED microparticles

被引:21
作者
Alcock, R
Blair, JA
O'Mahony, DJ
Raoof, A
Quirk, AV
机构
[1] Elan Drug Delivery Ltd, Nottingham NG11 6JS, England
[2] Trinity Coll Dublin, Elan Corp, Dublin 2, Ireland
关键词
leuprolide; controlled release; drug delivery; oligosaccharide ester derivatives; spray drying;
D O I
10.1016/S0168-3659(02)00165-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A range of oligosaccharide ester derivatives (OEDs) have been designed as drug delivery matrices for controlled release. The synthetic hormone analogue, leuprolide, was encapsulated within these matrices using hydrophobic ion pairing and solvent spray drying. The particles produced modified the release of leuprolide in vitro (dissolution in phosphate buffered saline) and in vivo (subcutaneous and pulmonary delivery in the rat). Release rate was dependent on drug loading and could be manipulated by choice of OED and by combining different OEDs in different ratios. Leuprolide encapsulated in the OEDs retained biological activity as evidenced by elevation in plasma luteinising hormone levels following subcutaneous injection of leuprolide recovered from OED particles in vitro prior to in vivo administration. (C) 2002 Elsevier Science BV All rights reserved.
引用
收藏
页码:429 / 440
页数:12
相关论文
共 18 条
[1]  
BLAIR J, 2002, RESP DRUG DELIVERY, V8, P105
[2]  
BRANNONPEPPAS, 2000, HDB PHARM CONTROLLED, P99
[3]   Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres [J].
Choi, SH ;
Park, TG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 203 (1-2) :193-202
[4]  
Cleland J L, 1997, Pharm Biotechnol, V10, P1
[5]  
GRIBBON EM, 1996, CHEM ASPECTS DRUG DE, P138
[6]   Stabilisation and delivery of labile materials by amorphous carbohydrates and their derivatives [J].
Hatley, RHM ;
Blair, JA .
JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 1999, 7 (1-4) :11-19
[8]   Technological considerations related to the up-scaling of protein microencapsulation by spray-drying [J].
Johansen, P ;
Merkle, HP ;
Gander, B .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (03) :413-417
[9]  
LANGNER E, 2002, P 7 EUR S CONTR DRUG, P136
[10]   APPROACHES FOR INCREASING THE SOLUTION STABILITY OF PROTEINS [J].
MANNING, MC ;
MATSUURA, JE ;
KENDRICK, BS ;
MEYER, JD ;
DORMISH, JJ ;
VRKLJAN, M ;
RUTH, JR ;
CARPENTER, JF ;
SHEFTER, E .
BIOTECHNOLOGY AND BIOENGINEERING, 1995, 48 (05) :506-512